FOLD
Amicus Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.56 / 10
Netural
Fund‑flow score is 6.96/10, showing overall positive inflows, especially from block and extra‑large investors, though medium and large flows turn negative. Analyst coverage is limited to one neutral rating, yielding a mixed sentiment environment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Dennis DingNeutral
Date2026-01-22
InstitutionJefferies
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of FOLD?
- FOLD holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.56/10 (Netural).
